Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B LIVINGSTON

Showing results (131-140 of 197) with videos related to

Pageof 20
Sort By:
Cancer|July 15, 1982
Phase II trial of 5-fluorouracil, adriamycin, mitomycin C, and streptozotocin (FAM-S) in pancreatic carcinomaR M Bukowski, L P Schacter, C W Groppe, et al.
Cancer|September 11, 1991
Alternating weekly doxorubicin and 5-fluorouracil/leucovorin followed by weekly doxorubicin and daily cyclophosphamide in stage IV breast cancer. A Southwest Oncology Group studyG K Ellis, S Green, S Schulman, et al.
Cancer|June 5, 1999
Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using [technetium 99m]-sestamibi scintimammographyD A Mankoff, L K Dunnwald, J R Gralow, et al.
Cancer Treatment Reports|July 1, 1984
Aggressive doxorubicin-containing regimen (prednisone, methotrexate, 5-FU, doxorubicin, and cyclophosphamide; PM-FAC) in disseminated estrogen receptor-negative breast cancerJ Mortimer, R B Livingston, I J Hardesty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
Reviving the pelvic examination for evaluating the status of ovarian carcinomaV L Seewaldt, J M Cain, B E Greer, et al.
Antibiotics and Chemotherapy|January 1, 1978
The clinical significance of prognostic factors in human neoplasiaJ S Hart, E Ignall, J M Trujillo, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1981
Therapy of thrombotic thrombocytopenic purpura: an overviewR M Bukowski, J S Hewlett, R R Reimer, et al.
Cancer Treatment Reports|June 1, 1985
Treatment of non-small cell bronchogenic carcinoma with vinblastine and mitomycin: a Southwest Oncology Group StudyJ K Weick, J M Rainey, R B Livingston, et al.
Cancer|August 1, 1975
COMB (cyclophosphamide, oncovin, methyl-CCNU, and bleomycin): a four-drug combination in solid tumorsR B Livingston, L H Einhorn, G P Bodey, et al.
American Journal of Obstetrics and Gynecology|June 1, 1996
Phase II study of high-dose cisplatin, etoposide, and cyclophosphamide for refractory ovarian cancerJ M Cain, C Collins, S Petersdorf, et al.
Pageof 20

Showing results (131-140 of 197) with videos related to

Sort By:
Pageof 20
Cancer|July 15, 1982
Phase II trial of 5-fluorouracil, adriamycin, mitomycin C, and streptozotocin (FAM-S) in pancreatic carcinomaR M Bukowski, L P Schacter, C W Groppe, et al.
Cancer|September 11, 1991
Alternating weekly doxorubicin and 5-fluorouracil/leucovorin followed by weekly doxorubicin and daily cyclophosphamide in stage IV breast cancer. A Southwest Oncology Group studyG K Ellis, S Green, S Schulman, et al.
Cancer|June 5, 1999
Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using [technetium 99m]-sestamibi scintimammographyD A Mankoff, L K Dunnwald, J R Gralow, et al.
Cancer Treatment Reports|July 1, 1984
Aggressive doxorubicin-containing regimen (prednisone, methotrexate, 5-FU, doxorubicin, and cyclophosphamide; PM-FAC) in disseminated estrogen receptor-negative breast cancerJ Mortimer, R B Livingston, I J Hardesty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
Reviving the pelvic examination for evaluating the status of ovarian carcinomaV L Seewaldt, J M Cain, B E Greer, et al.
Antibiotics and Chemotherapy|January 1, 1978
The clinical significance of prognostic factors in human neoplasiaJ S Hart, E Ignall, J M Trujillo, et al.
Seminars in Thrombosis and Hemostasis|January 1, 1981
Therapy of thrombotic thrombocytopenic purpura: an overviewR M Bukowski, J S Hewlett, R R Reimer, et al.
Cancer Treatment Reports|June 1, 1985
Treatment of non-small cell bronchogenic carcinoma with vinblastine and mitomycin: a Southwest Oncology Group StudyJ K Weick, J M Rainey, R B Livingston, et al.
Cancer|August 1, 1975
COMB (cyclophosphamide, oncovin, methyl-CCNU, and bleomycin): a four-drug combination in solid tumorsR B Livingston, L H Einhorn, G P Bodey, et al.
American Journal of Obstetrics and Gynecology|June 1, 1996
Phase II study of high-dose cisplatin, etoposide, and cyclophosphamide for refractory ovarian cancerJ M Cain, C Collins, S Petersdorf, et al.
Pageof 20